Current position:Home >Product >
N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]-5-phenyl-1,3-oxazole-2-carboxamide
N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]-5-phenyl-1,3-oxazole-2-carboxamide
|
|
Canonical SMILES:
CC(C)CN1C2=C(C=C(C=C2)NC(=O)C3=NC=C(O3)C4=CC=CC=C4)OCC(C1=O)(C)C
Isomeric SMILES
CC(C)CN1C2=C(C=C(C=C2)NC(=O)C3=NC=C(O3)C4=CC=CC=C4)OCC(C1=O)(C)C
InChI
InChI=1S/C25H27N3O4/c1-16(2)14-28-19-11-10-18(12-20(19)31-15-25(3,4)24(28)30)27-22(29)23-26-13-21(32-23)17-8-6-5-7-9-17/h5-13,16H,14-15H2,1-4H3,(H,27,29)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 1-(3,3-dimethyl-4-oxidanylidene-5-propyl-2H-1,5-benzoxazepin-8-yl)-3-[4-(trifluoromethyl)phenyl]urea
- N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]-5-phenyl-1,2-oxazole-3-carboxamide
- N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]-4-oxidanylidene-chromene-2-carboxamide
- 2,5-bis(chloranyl)-N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]benzamide
- 2,4-bis(chloranyl)-N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]benzamide
- 3,4-bis(chloranyl)-N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]benzamide
- N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]-7-methoxy-1-benzofuran-2-carboxamide
- (E)-3-(1,3-benzodioxol-5-yl)-N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]prop-2-enamide
- (E)-N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]-3-(4-nitrophenyl)prop-2-enamide
- N-[3,3-dimethyl-5-(2-methylpropyl)-4-oxidanylidene-2H-1,5-benzoxazepin-8-yl]cyclobutanecarboxamide

